Search Results - diagnostics > assay

2 Results Sort By:
Inducing Chemotherapeutic Sensitivity in Hyper-Transcription Diseases
This discovery is a method for the induction of sensitivity in tumor cells to a synergistic combination of PARP1 and ATR inhibition. It is applicable to hyper-transcription diseases , primarily cancers, including: Ewing sarcoma, acute myeloid leukemia, breast cancer, myelodysplastic syndrome, and possibly even Alzheimers and ALS. Background:Modern ...
Published: 8/23/2018   |   Inventor(s): Alexander Bishop, Aparna Gorthi, Carolina Romero, Liesl Lawrence
Keywords(s):  
Category(s): Clinical Specialty > Hematology, Clinical Specialty > Oncology, Clinical Specialty > Orthopedics, Diagnostics > Biomarkers, Diagnostics > Assay
Endocrine Therapy Diagnostic for ER+ Breast Cancer
UT Health San Antonio seeks to partner with a diagnostic products company to develop and commercialize a clinical diagnostic with the potential to determine if a patient with estrogen receptor (ER) positive breast cancer is suitable for treatment with endocrine therapy (e.g., tamoxifen and/or the aromatase inhibitors anastrozole (Arimidex®), le...
Published: 2/7/2013   |   Inventor(s): Amy Trauernicht, Thomas Boyer
Keywords(s): Biologics, Drugs
Category(s): Diagnostics > Assay, Clinical Specialty > Oncology, Clinical Specialty > Women's Health